beacon-intelligence.com Open in urlscan Pro
20.50.64.6  Public Scan

Form analysis
3 forms found in the DOM

GET /

<form class="search-form" method="get" action="/">
  <input type="text" name="s" placeholder="Search...">
</form>

GET https://beacon-intelligence.com/

<form role="search" method="get" class="wpr-search-form" action="https://beacon-intelligence.com/">
  <label for="search-form-62f253e5182e0"></label>
  <input type="search" class="wpr-search-field" placeholder="Search..." value="" name="s" title="Search for:">
  <button type="submit" class="wpr_submit">
    <i class="wpr-icon-search"></i>
  </button>
</form>

GET https://beacon-intelligence.com/

<form role="search" method="get" class="wpr-search-form" action="https://beacon-intelligence.com/">
  <label for="search-form-62f253e51ada4"></label>
  <input type="search" class="wpr-search-field" placeholder="Search..." value="" name="s" title="Search for:">
  <button type="submit" class="wpr_submit">
    <i class="wpr-icon-search"></i>
  </button>
</form>

Text Content

 * Home
 * Solutions
   * Beacon ADC
   * Beacon Adoptive Cell
   * Beacon Bispecific
   * Beacon Cancer Vaccine
   * Beacon Checkpoint
   * Beacon Cytokine
   * Beacon DDR
   * Beacon Gene Therapy
   * Beacon Microbiome
   * Beacon RNA
   * Beacon Oncolytic Viruses
   * Beacon TPD
 * About
   * News
 * Events
 * Resources
 * Contact
 * Login




MAKE FASTER AND BETTER INFORMED
DRUG DEVELOPMENT DECISIONS

In partnership with the world’s leading drug development
experts to help you keep up with the pace of preclinical and
clinical research developments.

Request a demoDownload brochure

MODULAR SOLUTIONS

Each Beacon Solution is designed specifically to focus on one therapeutic class.
Our sector specialist analysts curate preclinical and clinical data to remove
ambiguity and create an unrivalled depth of accuracy and analysis.

CLINICAL INTELLIGENCE

Beacon analysts work together with the scientific community to identify the most
relevant trends in the targeted therapy landscape and provide you with
cutting-edge reports to stay ahead in a rapidly evolving environment.

DEDICATED & EXPERT ANALYSTS

Gain access to personalized consultations with our analysts specific to your
project needs. Beacon analysts also maintain regular conversations with key
opinion leaders in the sector to enable you to make the most of your clinical
strategy.


TAILOR YOUR PACKAGE

ADC
Adoptive Cell
Bispecific
Cancer Vaccine
Checkpoint
Cytokine
DDR
Gene Therapy
Microbiome
RNA
Oncolytic Viruses
TPD

 

Covering all Antibody Drug Conjugates (ADCs), Small Molecule Drug Conjugates
(SMDCs), Protein Drug Conjugates (PDCs), Immunotoxins and more

Find out more

 

Covering all engineered and non-engineered immune cell therapies, including
CAR-T, TCR, NK, TILs, Gamma-Delta T Cells and more

Find out more

 

Covering all Bi- and Multi-Specific Antibodies, Antibody Fragments, Augmented
Antibodies and more

Find out more

 

Beacon Cancer Vaccine provides the solution you need to master the prophylactic
and therapeutic cancer vaccines field.

Find out more

 

Covering all Immune Checkpoint Combination Trials and Immune Checkpoint
Modulators in development across 27 different checkpoint targets

Find out more

 

Covering all cytokines and drugs that target a cytokine or its immediate
receptor belonging to the Interleukins, Interferons, Colony-stimulating factors,
Transforming growth factor β, Tumour necrosis factor and Chemokines families.

Find out more

 

Beacon DDR steps into the field to give drug developers the precise detailed
view and broader picture of what is truly happening in the DDR field.

Find out more

 

From gene-editing technologies, novel delivery systems, and a variety of genetic
materials being used – Beacon Gene Therapy steps into the field to give drug
developers a precise and detailed view of how the gene therapy landscape looks.

Find out more

 

Covering all pharmaceutical grade microbiome-based therapeutics across all
disease indications – Beacon Microbiome provides drug developers with detailed
views of the expanding microbiome landscape.

Find out more

 

Covering Oligonucleotide-based, mRNA-Based, Ribozyme, and gRNA-Mediated Gene
Editing therapies, as well as RNA-Targeted Small Molecules – Beacon RNA covers
all disease indications and many modalities to provide a detailed landscape of
the RNA space.

Find out more

 

From capturing viral family and strains to understanding any genetic
modifications – Beacon Oncolytic Viruses steps into the field to give drug
developers the precise detailed view and broader picture of what is truly
happening in the Oncolytic Virus field.

Find out more

 

Beacon TPD provides the solution you need to master the targeted protein
degradation field.

Find out more


LET US SHOW YOU WHAT WE DO

Find out how Beacon Targeted Therapies Solutions can aid you in your development
strategies and answer your key business questions about the landscape


BROWSE OUR DATABASE SOLUTIONS

Explore what Targeted Therapies we cover and how they can work to answer your
drug development questions or solve a business need‭.‬

View here


DOWNLOAD OUR BROCHURE

Find out more about how Beacon Targeted Therapies can assist you in answering
your business needs.

Download brochure


BLOG

Find out what the key trends and changes are with our latest infographics and
blogs with data sampled from our monthly modular reports.

View blog


SIGN UP FOR OUR FREE NEWSLETTERS

Get the latest stories of the week in short excerpts and how Beacon is tracking
this news.  Weekly and straight to your inbox.

Sign up now


WHAT OUR CUSTOMERS SAY


“I LOOK FORWARD TO USING BEACON. IT SAVES ME HOURS OF TRAWLING THROUGH FALSE
POSITIVE RESULTS TO MY SEARCHES.”

Head of Competitive Intelligence
Multinational Pharmaceutical Company


“I’VE RARELY SEEN SUCH DEDICATION FROM A SERVICE PROVIDER IN UNDERSTANDING AND
RESPONDING TO OUR NEEDS.”

Competitive Intelligence Manager
Top 20 Pharma


OUR LATEST CONTENT

ADOPTIVE CELL: MID-YEAR LANDSCAPE REVIEW 2022

Find out more

4-1BB LANDSCAPE REVIEW: SHIFT TOWARDS A BISPECIFIC THERAPEUTICS APPROACH

Find out more

ASCO 2022: ADC HIGHLIGHTS AND INSIGHTS

Find out more

USEFUL LINKS

 * About
 * Contact
 * Events
 * FAQS
 * Resources
 * Solutions
 * Careers

SOLUTIONS

 * Beacon Microbiome
 * Beacon Cytokine
 * Beacon TPD
 * Beacon Oncolytic Viruses
 * Beacon Checkpoint
 * Beacon Adoptive Cell

 * Beacon RNA
 * Beacon Cancer Vaccine
 * Beacon DDR
 * Beacon Gene Therapy
 * Beacon Bispecific
 * Beacon ADC

LATEST CONTENT

 * Adoptive Cell: Mid-Year Landscape Review 2022
 * 7th Oncolytic Virotherapy Summit 2022
 * 4-1BB Landscape Review: Shift Towards a Bispecific Therapeutics Approach
 * ASCO 2022: ADC Highlights and Insights
 * ASCO 2022: Bispecific Highlights and Insights

 * Terms & Conditions
 * Site Map

© 2022 TOAST DESIGN | Reg Office: 52 Grosvenor Gardens, London, SW1W 0AU. Beacon
is a trading name of Hanson Wade
Follow us on social media

 * 
 * Home
 * Solutions
   * Beacon ADC
   * Beacon Adoptive Cell
   * Beacon Bispecific
   * Beacon Cancer Vaccine
   * Beacon Checkpoint
   * Beacon Cytokine
   * Beacon DDR
   * Beacon Gene Therapy
   * Beacon Microbiome
   * Beacon RNA
   * Beacon Oncolytic Viruses
   * Beacon TPD
 * About
   * News
 * Events
 * Resources
 * Contact
 * Login
 * 
 * 





This is the brochure-popup

This is the contact us popup




Hover over page elements to highlight them, then click to create an annotation.